# AOV BioPharma, Inc. — Form D

AOV BioPharma, Inc. of SOUTH PASADENA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-09. The offering totals $55, of which $55 was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-05-09
- Form: D
- Accession: 0001775641-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $55
- Amount sold: $55
- Minimum investment: $5
- Investors: 3
- Date of first sale: 2019-04-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-339174

## Issuer

- Name: AOV BioPharma, Inc.
- CIK: 0001775641
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1708 LYNDON STREET, SOUTH PASADENA, CA, 91030
- Phone: (323) 516-4284

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Xiaojian Chen | Director | La Canada, CA |
| Dahai Gai | Director | Los Angeles, X1 |
| Dahai Gai | Executive Officer | Los Angeles, X1 |

## More

- [CIK 1775641 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1775641&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001775641-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.